スタッフ ログイン
Japanese |
English
ご質問・ご要望
一覧
検索
生物種別閲覧
登録
統計情報
検索
ホーム
一覧
論文
特許
論文 - 一覧
«
»
10 Hits
検索条件 : 絞込み (MeSH = Leukemia, Myeloid, Acute / drug therapy*)
生物種
リソース名
RRC ID
タイトル
ジャーナル
公開日
外部リンク
ヒト・動物細胞
EoL-1 cell(RCB0641)
77152
p53 is critical for the Aurora B kinase inhibitor-mediated apoptosis in acute myelogenous leukemia cells.
Int J Hematol
2010-1-1
Pubmed
Full text
ヒト・動物細胞
F-36P(RCB0775)
72576
Arsenic disulfide-triggered apoptosis and erythroid differentiation in myelodysplastic syndrome and acute myeloid leukemia cell lines.
Hematology
2014-9-1
Pubmed
Full text
ヒト・動物細胞
32Dcl3(RCB1377)
64539
Co-expression of wild-type FLT3 attenuates the inhibitory effect of FLT3 inhibitor on FLT3 mutated leukemia cells.
Oncotarget
2016-7-26
Pubmed
Full text
ヒト・動物細胞
RPMI8226(RCB3010)
,
KG-1(RCB1166)
,
MOLT-4(RCB0206)
63482
Targeting Notch-1 positive acute leukemia cells by novel fucose-bound liposomes carrying daunorubicin.
Oncotarget
2016-6-21
Pubmed
Full text
ヒト・動物細胞
M-MOK(RCB2534)
57794
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML.
Nat Commun
2019-5-16
Pubmed
Full text
実験動物マウス
RBRC01361
56700
Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms.
Sci Rep
2019-6-3
Pubmed
Full text
ヒト・動物細胞
K562/Adr(RCB1898)
56052
Knockdown of the Wnt receptor Frizzled-1 (FZD1) reduces MDR1/P-glycoprotein expression in multidrug resistant leukemic cells and inhibits leukemic cell proliferation.
Leuk Res
2018-4-1
Pubmed
Full text
ヒト・動物細胞
38313
Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia.
Int J Hematol
2010-11-1
Pubmed
Full text
ヒト・動物細胞
K562(RCB1897)
38106
In vivo selective imaging and inhibition of leukemia stem-like cells using the fluorescent carbocyanine derivative, DiOC5(3).
Biomaterials
2015-6-1
Pubmed
Full text
ヒト・動物細胞
HNT-34(RCB1296)
,
U-937 DE-4(RCB0435)
,
K562(RCB0027)
,
KG-1(RCB1166)
,
HL60(RCB0041)
,
THP-1(RCB1189)
17648
CD52 as a molecular target for immunotherapy to treat acute myeloid leukemia with high EVI1 expression.
Leukemia
2011-6-1
Pubmed
Full text